Scarica l'app Stockscreener
24.46
0.95%
0.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
Voya Investment Management LLC Has $8.79 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Texas Permanent School Fund Corp Boosts Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Wedge Capital Management L L P NC Makes New $2.86 Million Investment in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途牛牛
First Week of February 2026 Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
Toth Financial Advisory Corp Has $42,000 Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Market Fear: Can Catalyst Pharmaceuticals Inc. stock outperform in 2025 bull marketPortfolio Return Summary & AI Powered Market Entry Ideas - Улправда
Market Fear: Will Catalyst Pharmaceuticals Inc CN2 stock sustain bullish trend into 2025Quarterly Profit Review & Consistent Growth Stock Picks - moha.gov.vn
Can Catalyst Pharmaceuticals Inc. stock outperform in 2025 bull marketJuly 2025 Price Swings & Daily Momentum Trading Reports - Улправда
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now - MSN
Will Catalyst Pharmaceuticals Inc. stock see insider buyingPortfolio Performance Report & Fast Exit Strategy with Risk Control - Улправда
Why Catalyst Pharmaceuticals Inc. stock remains resilientQuarterly Market Summary & Safe Entry Momentum Stock Tips - DonanımHaber
What hedge fund moves indicate for Catalyst Pharmaceuticals Inc. (CN2) stock2025 Technical Patterns & Growth Focused Entry Reports - DonanımHaber
Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 - Yahoo Finance
How A New US$200 Million Buyback At Catalyst Pharmaceuticals (CPRX) Has Changed Its Investment Story - Yahoo Finance
Molly Harper Takes Money Off The Table, Sells $621K In Catalyst Pharmaceuticals Stock - Benzinga
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After Recent Share Price Gains - Sahm
Catalyst Pharmaceuticals (NASDAQ:CPRX) Director Molly Harper Sells 26,746 Shares - MarketBeat
Catalyst Pharmaceuticals CPRX Stock News, Forecasts and Analyst Outlook for December 15, 2025 - ts2.tech
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Castleark Management LLC Sells 123,370 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Does Catalyst Pharmaceuticals Still Offer Value After Its 559.8% Five Year Surge in 2025? - Sahm
Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi‑Year Share Price Surge? - Yahoo Finance
Globeflex Capital L P Increases Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) - Insider Monkey
JPMorgan Chase & Co. Buys 81,188 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Cresset Asset Management LLC Has $1.90 Million Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Transcript : Catalyst Pharmaceuticals, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 12 - marketscreener.com
How Investors Are Reacting To Catalyst Pharmaceuticals (CPRX) Upgraded 2025 Sales Outlook And Easing Short Interest - Sahm
Arrowstreet Capital Limited Partnership Purchases 188,594 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst (CPRX) Up 10% Since Last Earnings Report: Can It Continue? - sharewise.com
Kennedy Capital Management LLC Cuts Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceutical (CPRX) Recently Broke Out Above the 20-Day Moving Average - Finviz
Should I hold or sell Catalyst Pharmaceuticals Inc. stock in 2025Earnings Recap Report & Fast Moving Stock Watchlists - Newser
Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? - Yahoo Finance
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) (CPRX) - Seeking Alpha
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Catalyst Pharmaceuticals (CPRX) chair reports gifts of company stock to family trusts - Stock Titan
Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain bullish trend into 2025Market Activity Recap & Weekly Momentum Picks - Newser
Franklin Resources Inc. Boosts Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Can Catalyst Pharmaceuticals Inc. (CN2) stock hit consensus price targetsWeekly Trend Report & Verified Short-Term Trading Plans - Newser
CPRX SEC FilingsCatalyst Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Catalyst Pharmaceuticals (CPRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Transcript : Catalyst Pharmaceuticals, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 01 - marketscreener.com
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term - sharewise.com
How Catalyst Pharmaceuticals Inc. (CN2) stock behaves under inflation pressureJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
What valuation ratios show for Catalyst Pharmaceuticals Inc. (CN2) stockEarnings Recap Summary & Expert Verified Stock Movement Alerts - Newser
Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Published on: 2025-12-02 00:32:14 - Newser
0.36%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):